- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07425340
Ultrasound Examination of the VMO in Patellofemoral Pain Syndrome
February 13, 2026 updated by: Tuğba GÖNEN, Hasan Kalyoncu University
Ultrasonography Examination of the Vastus Medialis Obliquus and Vastus Medialis Longus Muscles in Patellofemoral Pain Syndrome
The aim of this study is to examine in detail the ultrasonographic characteristics of the vastus medialis obliquus and vastus medialis longus muscles in individuals with patellofemoral pain syndrome and to compare these findings with those of healthy individuals.
It is anticipated that the results obtained will contribute to a better understanding of the muscle-based mechanisms of PFAS and provide a scientific basis for the development of muscle-specific assessment and intervention strategies in physical therapy and rehabilitation practices.
Study Overview
Status
Not yet recruiting
Detailed Description
Patellofemoral pain syndrome (PFAS) is a musculoskeletal problem characterized by pain in the front of the knee joint, commonly seen in young and physically active individuals.
The etiology of PFAS is multifactorial and is associated with abnormal loading of the patella within the femoral trochlear groove, alterations in joint biomechanics, and functional deficiencies of the surrounding soft tissues.
These mechanical irregularities in the patellofemoral joint can lead to pain, loss of function, and activity limitations over time.
The quadriceps femoris muscle group plays a fundamental role in providing dynamic stability to the patella.
The vastus medialis obliquus (VMO) and vastus medialis longus (VML) muscles within this muscle group are critical for controlling the patella medially and maintaining its proper alignment within the femoral groove.
It is known that the oblique fiber structure of the VMO muscle provides medial stabilizing force to the patella, while the VML muscle contributes to force production during knee extension and overall patellar guidance with its longer fibers.
In individuals with PFAS, delayed activation patterns, decreased muscle strength, and morphological changes in the vastus medialis muscle have been reported.
However, it is observed in the literature that the VMO and VML muscles are treated as a single structure in most studies, and the separate morphological characteristics of these two muscles and their relationship with patellofemoral pain have not been sufficiently investigated.
However, the different anatomical, biomechanical, and functional characteristics of these muscles necessitate that their roles in PFAS pathophysiology be evaluated separately.
Ultrasonography is a non-invasive, reliable, and reproducible imaging method for evaluating the morphological characteristics of muscle tissue and is increasingly used in clinical research.
Ultrasonographic evaluation allows for the objective examination of muscle thickness, cross-sectional area, and architectural features, thereby providing important information about structural changes in muscle function.
The aim of this study is to examine in detail the ultrasonographic characteristics of the vastus medialis obliquus and vastus medialis longus muscles in individuals with patellofemoral pain syndrome and to compare these findings with healthy individuals.
It is anticipated that the results will contribute to the understanding of the muscle-based mechanisms of PFAS and provide a scientific basis for the development of muscle-specific assessment and intervention strategies in physical therapy and rehabilitation practices.
Study Type
Observational
Enrollment (Estimated)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tuğba GÖNEN, Asisst. Prof. Dr.
- Phone Number: 505 090 58 46
- Email: tugba.badat@hku.edu.tr
Study Locations
-
-
Şahinbey
-
Gaziantep, Şahinbey, Turkey (Türkiye), (505) 090-5846
- Hasan Kalyoncu University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
The study will include individuals aged 18-65 who have been diagnosed with patellofemoral pain syndrome, as well as healthy volunteers with similar characteristics in terms of age and gender.
The study group will consist of individuals who have applied to a physical therapy and rehabilitation clinic or who have been referred to relevant units.
The control group will be selected from healthy volunteers who do not have any knee pain or lower extremity musculoskeletal problems.
Description
Inclusion Criteria:
- Between the ages of 18 and 65
- Have had localized pain in the front of the knee for at least the past 3 months
- Experience pain during activities that require stair climbing, squatting, prolonged sitting, or knee flexion
- Have been diagnosed with patellofemoral pain syndrome based on clinical evaluation
- Volunteer to participate in the study and sign the informed consent form
Exclusion Criteria:
- History of previous surgery on the knee joint
- History of significant trauma to the knee region within the last 6 months
- Diagnosis of meniscus, ligament injuries, knee osteoarthritis, or inflammatory rheumatic disease
- Neurological diseases or systemic diseases affecting the musculoskeletal system
- Presence of other lower extremity pathologies causing pain at a level that could affect measurements
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Study Group
The study will include individuals aged 18-65 who have been diagnosed with patellofemoral pain syndrome, as well as healthy volunteers with similar characteristics in terms of age and gender.
|
|
Control group
The study will include individuals aged 18-65 who have been diagnosed with patellofemoral pain syndrome, as well as healthy volunteers with similar characteristics in terms of age and gender.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ultrasonographic Measurement
Time Frame: through of the study, average 4 months
|
A B-mode ultrasound device with a high-frequency (7-12 MHz) linear probe will be used to evaluate muscle architecture.
Ultrasound is a reliable, reproducible, and non-invasive imaging method for assessing the morphological characteristics of muscle tissue.
Ultrasonographic evaluations will be performed by an experienced researcher in musculoskeletal ultrasonography, in a quiet and standard environment.
A high-frequency (7-12 MHz) linear probe will be used during measurements.
Participants will be placed on the evaluation table in a supine position, with the knee joint fully extended and relaxed.
Before measurements, anatomical reference points will be determined using a tape measure, and temporary markings will be made on the skin.
Vastus Medialis Obliquus (VMO): VMO muscle thickness measurement will be performed in the region where the oblique orientation of the muscle fibers is prominent, using the upper-medial edge of the patella as a reference.
The measurement point will be determ
|
through of the study, average 4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tuğba GÖNEN, Asisst. Prof. Dr., Hasan Kalyoncu University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Engelina S, Antonios T, Robertson CJ, Killingback A, Adds PJ. Ultrasound investigation of vastus medialis oblique muscle architecture: an in vivo study. Clin Anat. 2014 Oct;27(7):1076-84. doi: 10.1002/ca.22413. Epub 2014 May 5.
- Castanov V, Hassan SA, Shakeri S, Vienneau M, Zabjek K, Richardson D, McKee NH, Agur AMR. Muscle architecture of vastus medialis obliquus and longus and its functional implications: A three-dimensional investigation. Clin Anat. 2019 May;32(4):515-523. doi: 10.1002/ca.23344. Epub 2019 Feb 19.
- Sawy MME, Mikkawy DMEE, El-Sayed SM, Desouky AM. Morphometric analysis of vastus medialis oblique muscle and its influence on anterior knee pain. Anat Cell Biol. 2021 Mar 31;54(1):1-9. doi: 10.5115/acb.20.258.
- Davut S, Dogramaci Y. Evaluation of the relationship between the anatomical characteristics of the vastus medialis obliquus muscle and the patella chondral lesion occurrence. Jt Dis Relat Surg. 2024 Apr 26;35(2):330-339. doi: 10.52312/jdrs.2024.771. Epub 2024 Apr 26.
- Dong C, Li M, Hao K, Zhao C, Piao K, Lin W, Fan C, Niu Y, Fei W. Dose atrophy of vastus medialis obliquus and vastus lateralis exist in patients with patellofemoral pain syndrome. J Orthop Surg Res. 2021 Feb 10;16(1):128. doi: 10.1186/s13018-021-02251-6.
- Smith TO, Nichols R, Harle D, Donell ST. Do the vastus medialis obliquus and vastus medialis longus really exist? A systematic review. Clin Anat. 2009 Mar;22(2):183-99. doi: 10.1002/ca.20737.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
February 25, 2026
Primary Completion (Estimated)
April 25, 2026
Study Completion (Estimated)
June 25, 2026
Study Registration Dates
First Submitted
February 13, 2026
First Submitted That Met QC Criteria
February 13, 2026
First Posted (Actual)
February 20, 2026
Study Record Updates
Last Update Posted (Actual)
February 20, 2026
Last Update Submitted That Met QC Criteria
February 13, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025/161
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vastus Medialis
-
Smith & Nephew, Inc.CompletedACL Repair | Posterior Cruciate Ligament (PCL) Repair | Medial Collateral Ligament (MCL) | Lateral Collateral Ligament (LCL) | Posterior Oblique Ligament (POL) | Patellar Realignment and Tendon Repairs | Vastus Medialis Obliquus Advancement | Iliotibial Band Tenodesis | Extra-capsular Repairs | Knee RepairUnited States
-
Kafrelsheikh UniversityRecruitingAnalgesia | Lateral Femoral Cutaneous Nerve Block | Vastus Lateralis Nerve Block | Knee SurgeriesEgypt
-
Smith & Nephew, Inc.CompletedBankart Lesion | Acetabular Labrum Tear | SLAP Lesion | Acromioclavicular Sprain | Capsular Shift/Capsulolabral Reconstruction | Deltoid Repair | Rotator Cuff Repair | Bicep Tendinitis | Extra-capsular Repair | Medial Collateral Ligament | Lateal Collateral Ligament | Posterior Oblique Ligament | IBT | Vastus Medialis and other conditionsUnited States